Intuitive Surgical, Inc. (ISRG) Trading Down 198.5%

Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) were down 198.5% during mid-day trading on Friday . The company traded as low as $360.20 and last traded at $361.47. Approximately 889,588 shares were traded during trading, an increase of 190% from the average daily volume of 306,954 shares. The stock had previously closed at $121.08.

A number of analysts recently issued reports on ISRG shares. Stifel Nicolaus reiterated a “buy” rating and set a $122.22 price objective (up from $94.44) on shares of Intuitive Surgical in a research note on Saturday, July 22nd. Leerink Swann restated an “outperform” rating on shares of Intuitive Surgical in a research report on Wednesday, July 5th. Wedbush restated an “outperform” rating and set a $353.33 target price on shares of Intuitive Surgical in a research report on Monday, September 25th. Morgan Stanley restated an “overweight” rating on shares of Intuitive Surgical in a research report on Tuesday, September 5th. Finally, Royal Bank Of Canada boosted their target price on Intuitive Surgical from $88.89 to $105.56 and gave the stock a “sector perform” rating in a research report on Tuesday, July 18th. Five investment analysts have rated the stock with a hold rating, thirteen have issued a buy rating and one has assigned a strong buy rating to the stock. The stock currently has a consensus rating of “Buy” and a consensus price target of $137.11.

The company has a market capitalization of $42.06 billion, a P/E ratio of 57.90 and a beta of 0.39. The firm’s 50 day moving average price is $342.46 and its 200-day moving average price is $305.94.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings results on Thursday, July 20th. The medical equipment provider reported $0.66 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.64 by $0.02. Intuitive Surgical had a return on equity of 15.99% and a net margin of 28.44%. The company had revenue of $756.20 million during the quarter, compared to analyst estimates of $724.51 million. During the same quarter last year, the business posted $0.62 earnings per share. The firm’s revenue was up 12.8% on a year-over-year basis. On average, equities research analysts expect that Intuitive Surgical, Inc. will post $23.92 earnings per share for the current year.

In other Intuitive Surgical news, SVP Curet Myriam sold 1,202 shares of the business’s stock in a transaction that occurred on Tuesday, July 25th. The stock was sold at an average price of $950.20, for a total transaction of $1,142,140.40. Following the completion of the transaction, the senior vice president now owns 1,428 shares in the company, valued at $1,356,885.60. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO Gary S. Guthart sold 17,975 shares of the business’s stock in a transaction that occurred on Thursday, July 27th. The shares were sold at an average price of $937.27, for a total value of $16,847,428.25. Following the transaction, the chief executive officer now owns 101,798 shares of the company’s stock, valued at approximately $95,412,211.46. The disclosure for this sale can be found here. Insiders have sold 23,172 shares of company stock valued at $21,923,487 in the last 90 days. Company insiders own 2.20% of the company’s stock.

Several large investors have recently made changes to their positions in the business. Eqis Capital Management Inc. boosted its position in shares of Intuitive Surgical by 17.2% during the third quarter. Eqis Capital Management Inc. now owns 408 shares of the medical equipment provider’s stock valued at $427,000 after buying an additional 60 shares during the period. Paulson & CO. Inc. raised its stake in shares of Intuitive Surgical by 37.8% during the second quarter. Paulson & CO. Inc. now owns 10,200 shares of the medical equipment provider’s stock valued at $9,541,000 after acquiring an additional 2,800 shares in the last quarter. W. E. Donoghue & Co. LLC bought a new stake in shares of Intuitive Surgical during the second quarter valued at approximately $2,306,000. Lord Abbett & CO. LLC raised its stake in shares of Intuitive Surgical by 55.5% during the second quarter. Lord Abbett & CO. LLC now owns 62,078 shares of the medical equipment provider’s stock valued at $58,066,000 after acquiring an additional 22,152 shares in the last quarter. Finally, USA Financial Portformulas Corp bought a new stake in shares of Intuitive Surgical during the second quarter valued at approximately $2,905,000. Institutional investors and hedge funds own 94.23% of the company’s stock.

ILLEGAL ACTIVITY NOTICE: This article was originally published by Transcript Daily and is the property of of Transcript Daily. If you are reading this article on another site, it was illegally stolen and republished in violation of U.S. and international trademark & copyright law. The legal version of this article can be viewed at https://transcriptdaily.com/2017/10/08/intuitive-surgical-inc-isrg-trading-down-198-5.html.

About Intuitive Surgical

Intuitive Surgical, Inc (Intuitive) designs, manufactures and markets da Vinci Surgical Systems, and related instruments and accessories. The Company’s da Vinci Surgical System consists of a surgeon’s console, a patient-side cart and a vision system. The da Vinci Surgical System translates a surgeon’s hand movements, which are performed on instrument controls at a console, into corresponding micro-movements of instruments positioned inside the patient through small incisions or ports.

Receive News & Ratings for Intuitive Surgical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply